Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Public Relations; Health Care
Companies Profiled:
Abbvie; Adamas Pharmaceuticals; AstraZeneca; Biogen; Bayer; Catalyst Pharmaceuticals; FleishmanHillard; Fresenius Medical Care AG & Co. KGaA; Genzyme; Indivior; Lilly; Merck; Novartis; Prometheus Therapeutics & Diagnostics; Tokai Pharmaceuticals; Vertex Pharmaceuticals; ZS Pharma
Table of Contents
· Executive Summary, pgs. 4-8
ü Research Overview, pg. 4
ü Participating Companies, pg. 5
ü Key Findings Overview, pg. 6
ü Key Insights Overview, pg. 7
ü Overview of DA Timing, pgs. 8
I. Participant Demographics, pgs. 9-13
II. Program Effectiveness and Structure, pgs. 14-19
III. Timing of Disease Awareness Activities, pgs. 20-27
IV. Disease Awareness Budget and Spend, pgs. 28-36
V. Involvement of Advocacy and Legal, pgs. 37-45
VI. Social Media, pgs. 46-53
VII. Best Practices and Pitfalls, pgs. 54-56
VIII. Narratives from Interviews, pgs. 57-66
VIIII. Key Findings, pgs. 67-72
X. Appendix, pgs. 73-78
· About Best Practices, LLC, pg. 79
List of Charts & Exhibits
· Disease Awareness (DA) Program Effectiveness
· Disease Awareness Organizational Structure
· Functional Involvement & Leadership in DA
· Presence of Distinct Disease Awareness Group
· Start and End Point of Disease Awareness Efforts
· Timing for Disease Awareness Activities
· Most Heavily Used Disease Awareness Activities
· Factors Influencing the Amount of Resources Dedicated to Disease Awareness Programs on a Product-by-Product Basis
· Percentage of Peak-year Sale Projections Spent on the Disease State Awareness Program for a Typical Product Across its Entire Lifecycle
· Company-Wide Budget for Disease Awareness Initiatives, Activities and Programs
· Functions Providing Funding for Disease Awareness Programs
· Peak Investment Year for Disease Awareness Initiatives
· Percentage of Total Disease Awareness Budget for a New Product Allocated to Different Product Stages
· Peak Year Investment for Disease Awareness
· Additional Disease Awareness Investment Needed for Unmet Need Products
· Importance Level of DA Activities with Advocacy Groups
· Keys to Developing a Good Relationship with Advocacy
· Approaches to Support Disease Awareness Activities with Patient Advocacy Groups
· Timing of Disease Awareness Activities with Patient Advocacy Groups
· Level of Involvement of the Organization's Legal Department in Different Disease Awareness Program Areas
· Legal Review Requirements for Key Markets
· Disease State Awareness (DSA) Social Media Activities
· Patient Access via Social media
· Utilization Ranking of Social Media Activities
· Social Media Spend for Disease Awareness
· Social Media DA Spend and Percentage of DA Budget
· Best Practices for Maintaining An Effective Disease State Awareness Program
· Pitfalls To An Effective Disease Awareness Program